THE RISK OF DEATH ASSOCIATED WITH PROTEINURIA IN HEART FAILURE IS RESTRICTED TO PATIENTS WITH AN ELEVATED BLOOD UREA NITROGEN TO CREATININE RATIO: AN APPLICATION OF THE SOLVD TRIAL LIMITED DATASET  by Brisco, Meredith Ann et al.
Heart Failure
E760
JACC March 12, 2013
Volume 61, Issue 10
The risk of deaTh associaTed wiTh proTeinuria in hearT failure is resTricTed To paTienTs 
wiTh an elevaTed Blood urea niTrogen To creaTinine raTio: an applicaTion of The solvd 
Trial limiTed daTaseT
Poster Contributions
Poster Sessions, Expo North
Sunday, March 10, 2013, 3:45 p.m.-4:30 p.m.
Session Title: New Paradigms in Prognostic Role of Biomarkers in Heart Failure
Abstract Category: 15. Heart Failure: Clinical
Presentation Number: 1265-312
Authors: Meredith Ann Brisco, Stephen Kimmel, Jeffrey Testani, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 
USA, Yale University School of Medicine, New Haven, CT, USA
Background: In heart failure (HF), renal dysfunction (RD) is associated with reduced survival; however, evidence indicates that that not all causes 
of RD are prognostically equivalent. Notably, the risk attributable to a reduced estimated glomerular filtration rate (eGFR) is largely restricted 
to patients with an elevated blood urea nitrogen to creatinine ratio (BUN/Cr; a surrogate for “pre-renal” physiology such as HF-induced RD). 
Independent of eGFR, proteinuria has also been associated with adverse events. Proteinuria can also be caused by several different mechanisms 
and a “functional” form of proteinuria induced by renal neurohormonal activation (i.e., “pre-renal” physiology) has been well described.
methods: Subjects in the Studies Of Left Ventricular Dysfunction (SOLVD) trial limited dataset with urinary protein assessed at baseline (dipstick) 
were studied (n=6,520). All survival models were fully adjusted for baseline characteristics, including eGFR.
results: Proteinuria (trace or 1+) was present in 26% of the population and associated with increased mortality (HR=1.2, 95% CI 1.1-1.3, 
p=0.004). Proteinuria ≥2+ was less common (2.5%) but demonstrated a stronger relationship with mortality (HR=1.9, 95% CI 1.5-2.4, p<0.0001). 
In patients with a BUN/Cr in the top tertile (≥17.3), both any (HR=1.4, 95% CI 1.1-1.6, p=0.001) and ≥2+ proteinuria (HR=2.0, 95% CI 1.4-2.8, 
p<0.0001) were associated with increased mortality. However, in patients with a BUN/Cr in the bottom tertile (≤13.3), any proteinuria (HR=1.0, 
95% CI 0.8-1.2, p=0.96, p interaction= 0.006) and ≥2+ proteinuria (HR=1.3, 95% CI 0.8-2.1, p=0.27, p interaction=0.06) were not associated with 
significantly worsened survival.
conclusion: Analogous to a reduced eGFR, the mechanism underlying proteinuria may be important in determining the associated survival 
disadvantage. Additional research is necessary to better understand and characterize different phenotypes of RD in HF.
